Market Place
Sourcing Support
Blue Water changes tides again, dropping all vaccine programs
30 Oct 2023 //
FIERCE BIOTECH
LAVA winds down bispecific trial; Blue Water buys 6 marketed drugs for $8.5M
14 Jun 2023 //
ENDPTS
Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech
24 Apr 2023 //
GLOBENEWSWIRE
Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign
20 Apr 2023 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Signing of Agreement with The University of Texas Health Science Center
12 Apr 2023 //
GLOBENEWSWIRE
Blue Water Vaccines Reports Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Blue Water Vaccines AppointsLeader Frank Jaeger as Senior Vice President
06 Feb 2023 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Partnership with AbVacc for Vaccine Candidates
01 Feb 2023 //
GLOBENEWSWIRE
Blue Water Announces Appointment of Timothy Ramdeen to Board of Directors
17 Jan 2023 //
GLOBENEWSWIRE
Blue Water Vaccines to Present During 41st J.P. Morgan Healthcare Conference
09 Jan 2023 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Institutional Research Coverage by Two Notable
12 Dec 2022 //
GLOBENEWSWIRE
Blue Water to Present Update on Novel, Live Attenuated, Intranasally Delivered
01 Dec 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Agreement for Chlamydia Development
21 Nov 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Reports 3Q 2022 Financial Results and Recent Highlights
10 Nov 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Appoints Vuk Jeremi? to Its Board of Directors
08 Nov 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Plans to Evaluate Efficacy of pneumoniae
11 Oct 2022 //
GLOBENEWSWIRE
Blue Water Vaccines to Present In Person and via Webcast at H.C. Wainwright’s
08 Sep 2022 //
GLOBENEWSWIRE
Blue Water Vaccines to Present at H.C. Wainwright’s 24th Annual Global
31 Aug 2022 //
GLOBENEWSWIRE
Blue Water to Present at The Universal Influenza Vaccines 2022 Conference
24 Aug 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Appointment of Simon Tarsh to Board of Directors
22 Aug 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Exploration of Its VLP Platform
17 Aug 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Closing of $10 Million Private Placement
11 Aug 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces $10 Million Private Placement Priced
09 Aug 2022 //
GLOBENEWSWIRE
With SPACs` high tide long gone, Blue Water ditches second blank check voyage
04 Aug 2022 //
ENDPTS
Blue Water Vaccines Announces Signing of Sponsored Research Agreement with CCHMC
20 Jul 2022 //
GLOBENEWSWIRE
Blue Water Vaccines to Present at the JMP Securities Life Science Conference
06 Jun 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Sponsored Research Agreement Amendment
31 May 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Collaboration with Instituto Butantan for BWV-101
19 May 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Reports First Quarter 2022 Financial Results
13 May 2022 //
GLOBENEWSWIRE
Blue Water Vaccines to Present at H.C. Wainwright Global Investment Conference
12 May 2022 //
GLOBENEWSWIRE
Blue Water Vaccines stock rallies 26%
11 May 2022 //
SEEKING ALPHA
Blue Water Vaccines Announces Expanded License Agreement
11 May 2022 //
GLOBENEWSWIRE
Blue Water Vaccines stock jumps 40%, but still trading below IPO price
03 May 2022 //
SEEKING ALPHA
Blue Water Vaccines Announces Closing of $8M Private Placement
20 Apr 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces $8M Private Placement Priced Under Nasdaq Rules
13 Apr 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022
11 Apr 2022 //
GLOBENEWSWIRE
Blue Water Vaccines shares plummet 80% weeks after $20M IPO
08 Apr 2022 //
BIZJOURNALS
Blue Water Vaccines Announces Publication in Nano Research
22 Mar 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Closing of Initial Public Offering
23 Feb 2022 //
GLOBENEWSWIRE
Blue Water Vaccines Announces Pricing of approximate $20M IPO
17 Feb 2022 //
PRNEWSWIRE
Vaccine biotech Blue Water Vaccines sets terms for $20 million IPO
05 Nov 2021 //
PRESSRELEASE
Annual report which provides a comprehensive overview of the company for the past year
31 Mar 2021 //
PRESS RELEASE
